Physician profile
Matthew E Beuerlein
NPI 1891763363
$376.23
in general payments reported to CMS, 2019-2025
9 companies · $21.86 in 2025
The $21.86 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.31 · 2021: $133 · 2022: $70.05 · 2023: $98.99 · 2024: $18.93 · 2025: $21.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $98.99 · Food and Beverage: $40.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $98.99 |
| Food and Beverage | $40.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $98.99 | 2023 | |
| Acclarent, INC | $80.17 | 2021-2022 | |
| Glaxosmithkline, LLC. | $50.00 | 2021 | |
| Stryker Corporation | $47.05 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $25.92 | 2021 | |
| Karl Storz Endoscopy-America | $21.86 | 2025 | |
| Integra Lifesciences Corporation | $18.93 | 2024 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Intersect Ent, INC. | $17.96 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Beuerlein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.